The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor.

This study is currently recruiting participants.

Study NCT00404768 Information provided by GlaxoSmithKline

First Received: November 27, 2006 Last Updated: November 5, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	May 2010 (Final data collection date for primary outcome measure)